FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Patrick Robberecht

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Concepts & Ideas

Molecular Sequence Data

Genes & Molecular Sequences

Amino Acid Sequences

Physiology

Co-author Network

Publications

TOP 3
Ingrid Langer; Karelle Leroy; Nathalie Gaspard; Jean-Pierre Brion; Patrick Robberecht
Cell surface targeting of VPAC1 receptors: evidence for implication of a quality control system and the proteasome.
Salvatore De Maria; Vittoria Metafora; Salvatore Metafora; Gianpietro Ravagnan; Maria Cartení; Gabriele Pontoni; Angelo M Facchiano; Marilena Lepretti; Beatrice Severino; Giuseppe Caliendo; Vincenzo Santagada; Ingrid Langer; Patrick Robberecht
Effect of positive charge in VIP 16gamma-glutamyl diamino derivatives on hVPAC1 and hVPAC2 receptor function.
Ingrid Langer; Patrick Robberecht
Molecular mechanisms involved in vasoactive intestinal peptide receptor activation and regulation: current knowledge, similarities to and differences from the A family of G-protein-coupled receptors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Patrick Robberecht (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Ingrid Langer; Karelle Leroy; Nathalie Gaspard; Jean-Pierre Brion; Patrick Robberecht
Cell surface targeting of VPAC1 receptors: evidence for implication of a quality control system and the proteasome.
Biochimica et biophysica acta 2008;1783(9):1663-72.
2008: Salvatore De Maria; Vittoria Metafora; Salvatore Metafora; Gianpietro Ravagnan; Maria Cartení; Gabriele Pontoni; Angelo M Facchiano; Marilena Lepretti; Beatrice Severino; Giuseppe Caliendo; Vincenzo Santagada; Ingrid Langer; Patrick Robberecht
Effect of positive charge in VIP 16gamma-glutamyl diamino derivatives on hVPAC1 and hVPAC2 receptor function.
Journal of peptide science : an official publication of the European Peptide Society 2008;14(1):102-9.
2007: Ingrid Langer; Patrick Robberecht
Molecular mechanisms involved in vasoactive intestinal peptide receptor activation and regulation: current knowledge, similarities to and differences from the A family of G-protein-coupled receptors.
Biochemical Society transactions 2007;35(Pt 4):724-8.
2006: Ingrid Nachtergael; Nathalie Gaspard; Christelle Langlet; Patrick Robberecht; Ingrid Langer
Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
Cellular signalling 2006;18(12):2121-30.
2006: Ingrid Langer; Nathalie Gaspard; Patrick Robberecht
Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2).
British journal of pharmacology 2006;148(8):1051-9.
2006: Christelle Langlet; Ingrid Nachtergael; Patrick Robberecht; Ingrid Langer
Mutation of the phosphorylatable residue Thr429 in Glu of the human VPAC1 led to a constitutively desensitized receptor.
Peptides 2006;27(7):1865-70.
2005: Luo Xu; Inge Depoortere; Pascale Vertongen; Magali Waelbroeck; Patrick Robberecht; Theo L Peeters
Motilin and erythromycin-A share a common binding site in the third transmembrane segment of the motilin receptor.
Biochemical pharmacology 2005;70(6):879-87.
2005: Christelle Langlet; Ingrid Langer; Pascale Vertongen; Nathalie Gaspard; Jean-Marie Vanderwinden; Patrick Robberecht
Contribution of the carboxyl terminus of the VPAC1 receptor to agonist-induced receptor phosphorylation, internalization, and recycling.
The Journal of biological chemistry 2005;280(30):28034-43.
2005: Leen Thielemans; Inge Depoortere; Jason Perret; Patrick Robberecht; Yaoquan Liu; Theo Thijs; Chris Carreras; Emmanuel Burgeon; Theo L Peeters
Desensitization of the human motilin receptor by motilides.
The Journal of pharmacology and experimental therapeutics 2005;313(3):1397-405.
2005: Ingrid Langer; Christelle Langlet; Patrick Robberecht
Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor.
Journal of molecular endocrinology 2005;34(2):405-14.
2005: Carine De Vriese; Françoise Grégoire; Philippe De Neef; Patrick Robberecht; Christine Delporte
Ghrelin is produced by the human erythroleukemic HEL cell line and involved in an autocrine pathway leading to cell proliferation.
Endocrinology 2005;146(3):1514-22.
2005: Isabelle Migeotte; Elena Riboldi; Jean-Denis Franssen; Françoise Grégoire; Cécile Loison; Valérie Wittamer; Michel detheux; Patrick Robberecht; Sabine Costagliola; Gilbert Vassart; Silvano Sozzani; Marc Parmentier; David Communi
Identification and characterization of an endogenous chemotactic ligand specific for FPRL2.
The Journal of experimental medicine 2005;201(1):83-93.
2005: Ingrid Langer; Patrick Robberecht
Mutations in the carboxy-terminus of the third intracellular loop of the human recombinant VPAC1 receptor impair VIP-stimulated [Ca2+]i increase but not adenylate cyclase stimulation.
Cellular signalling 2005;17(1):17-24.
2004: Christelle Langlet; Nathalie Gaspard; Ingrid Nachtergael; Patrick Robberecht; Ingrid Langer
Comparative efficacy of VIP and analogs on activation and internalization of the recombinant VPAC2 receptor expressed in CHO cells.
Peptides 2004;25(12):2079-86.
2004: Pascale Vertongen; Christelle Langlet; Ingrid Langer; Nathalie Gaspard; Patrick Robberecht
Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors.
Peptides 2004;25(11):1943-9.
2004: Carine De Vriese; Françoise Gregoire; Roger Lema-Kisoka; Magali Waelbroeck; Patrick Robberecht; Christine Delporte
Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites.
Endocrinology 2004;145(11):4997-5005.
2004: Mélanie Van Craenenbroeck; Françoise Gregoire; Philippe De Neef; Patrick Robberecht; Jason Perret
Ala-scan of ghrelin (1-14): interaction with the recombinant human ghrelin receptor.
Peptides 2004;25(6):959-65.
2004: Anna Costagliola; Joris G De Man; Mariusz Majewski; Mirek Lakomy; Aldo Cecio; Patrick Robberecht; Paul A Pelckmans; Dirk Adriaensen; Jean-Pierre Timmermans
Coexistence of non-adrenergic non-cholinergic inhibitory and excitatory neurotransmitters in a large neuronal subpopulation in the vaginal segment of the chicken oviduct.
Autonomic neuroscience : basic & clinical 2004;112(1-2):37-48.
2004: Valérie Wittamer; Françoise Grégoire; Patrick Robberecht; Gilbert Vassart; David Communi; Marc Parmentier
The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency.
The Journal of biological chemistry 2004;279(11):9956-62.
2004: Ingrid Langer; Françoise Gregoire; Ingrid Nachtergael; Philippe De Neef; Pascale Vertongen; Patrick Robberecht
Hexanoylation of a VPAC2 receptor-preferring ligand markedly increased its selectivity and potency.
Peptides 2004;25(2):275-8.
2003: Inge Depoortere; Theo Thijs; Leen Thielemans; Patrick Robberecht; Theo L Peeters
Interaction of the growth hormone-releasing peptides ghrelin and growth hormone-releasing peptide-6 with the motilin receptor in the rabbit gastric antrum.
The Journal of pharmacology and experimental therapeutics 2003;305(2):660-7.
2003: Ingrid Nachtergael; Pascale Vertongen; Ingrid Langer; Jason Perret; Patrick Robberecht; Magali Waelbroeck
Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor.
The Biochemical journal 2003;370(Pt 3):1003-9.
2003: Ingrid Langer; Pascale Vertongen; Jason Perret; Magali Waelbroeck; Patrick Robberecht
Lysine 195 and aspartate 196 in the first extracellular loop of the VPAC1 receptor are essential for high affinity binding of agonists but not of antagonists.
Neuropharmacology 2003;44(1):125-31.
2002: Ingrid Langer; Pascale Vertongen; Jason Perret; Magali Waelbroeck; Patrick Robberecht
A small sequence in the third intracellular loop of the VPAC(1) receptor is responsible for its efficient coupling to the calcium effector.
Biochemical Society transactions 2002;30(4):447-50.
2002: Magali Waelbroeck; Jason Perret; Pascale Vertongen; Mélanie Van Craenenbroeck; Patrick Robberecht
Identification of secretin, vasoactive intestinal peptide and glucagon binding sites: from chimaeric receptors to point mutations.
Biochemical Society transactions 2002;30(4):437-41.
2002: Christine Fagny; Michel Vandevelde; Michal Svoboda; Patrick Robberecht
Ribonucleotide reductase and thymidine phosphorylation: two potential targets of azodicarbonamide.
Biochemical pharmacology 2002;64(3):451-6.
2002: Jason Perret; Pascale Vertongen; RM Solano; Ingrid Langer; Johnny Cnudde; Patrick Robberecht; Magali Waelbroeck
Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation.
British journal of pharmacology 2002;136(7):1042-8.
2002: Ingrid Langer; Pascale Vertongen; Jason Perret; Johnny Cnudde; Françoise Gregoire; Philippe De Neef; Patrick Robberecht; Magali Waelbroeck
VPAC(1) receptors have different agonist efficacy profiles on membrane and intact cells.
Cellular signalling 2002;14(8):689-94.
2002: Salvatore De Maria; Salvatore Metafora; Vittoria Metafora; Francesco Morelli; Patrick Robberecht; Magali Waelbroeck; Paola Stiuso; Alfredo De Rosa; Anna Cozzolino; Carla Esposito; Angelo M Facchiano; Maria Cartenì
Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates VIP/PACAP receptor activity.
European journal of biochemistry / FEBS 2002;269(13):3211-9.
2002: Ingrid Langer; Pascale Vertongen; Jason Perret; Magali Waelbroeck; Patrick Robberecht
A small sequence in the third intracellular loop of the VPAC(1) receptor is responsible for its efficient coupling to the calcium effector.
Molecular endocrinology (Baltimore, Md.) 2002;16(5):1089-96.
2002: Jason Perret; Mélanie Van Craenenbroeck; Ingrid Langer; Pascale Vertongen; Françoise Gregoire; Patrick Robberecht; Magali Waelbroeck
Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue.
The Biochemical journal 2002;362(Pt 2):389-94.
2001: Roger Lema-Kisoka; N Hayez; Ingrid Langer; Patrick Robberecht; Eric Sariban; Christine Delporte
Characterization of functional VIP/PACAP receptors in the human erythroleukemic HEL cell line.
Peptides 2001;22(12):2155-62.
2001: María G Juarranz; Oscar Bolaños; Irene Gutiérrez-Cañas; E A Lerner; Patrick Robberecht; María J Carmena; Juan Prieto; Nieves Rodríguez-Henche
Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors.
Cellular signalling 2001;13(12):887-94.
2001: Ingrid Langer; Jason Perret; Pascale Vertongen; Magali Waelbroeck; Patrick Robberecht
Vasoactive intestinal peptide (VIP) stimulates [Ca2+]i and cyclic AMPin CHO cells expressing Galpha16.
Cell calcium 2001;30(4):229-34.
2001: H Dahma; P Gourlet; A Vandermeers; MC Vandermeers-Piret; Patrick Robberecht
Evidence that the chromogranin B fragment 368-417 extracted from a pheochromocytoma is phosphorylated.
Peptides 2001;22(9):1491-9.
2001: Pascale Vertongen; RM Solano; María G Juarranz; Jason Perret; Magali Waelbroeck; Patrick Robberecht
Proline residue 280 in the second extracellular loop (EC2) of the VPAC2 receptor is essential for the receptor structure.
Peptides 2001;22(9):1363-70.
2001: Pascale Vertongen; RM Solano; Jason Perret; Ingrid Langer; Patrick Robberecht; Magali Waelbroeck
Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix.
British journal of pharmacology 2001;133(8):1249-54.
2001: RM Solano; Ingrid Langer; Jason Perret; Pascale Vertongen; María G Juarranz; Patrick Robberecht; Magali Waelbroeck
Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction.
The Journal of biological chemistry 2001;276(2):1084-8.
2000: D Moreno; P Gourlet; Philippe De Neef; Johnny Cnudde; Magali Waelbroeck; Patrick Robberecht
Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor.
Peptides 2000;21(10):1543-9.
2000: I Langer; G Atassi; Patrick Robberecht; A Résibois
Eriochrome Black T inhibits endothelial cell growth through S-phase blockade.
European journal of pharmacology 2000;399(2-3):85-90.
2000: MC Vandermeers-Piret; A Vandermeers; P Gourlet; M H Ali; Magali Waelbroeck; Patrick Robberecht
Evidence that the lizard helospectin peptides are O-glycosylated.
European journal of biochemistry / FEBS 2000;267(14):4556-60.
2000: J Van Rampelbergh; María G Juarranz; Jason Perret; A Bondue; RM Solano; Christine Delporte; Philippe De Neef; Patrick Robberecht; Magali Waelbroeck
Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition.
British journal of pharmacology 2000;130(4):819-26.
2000: María G Juarranz; J Van Rampelbergh; P Gourlet; Magali Waelbroeck; Patrick Robberecht
Different domains of the VIP receptors modulate agonist affinity and intrinsic activity.
Annals of the New York Academy of Sciences 2000;921():395-9.
2000: Patrick Robberecht; E Di Paolo; N Moguilevsky; A Bollen; Magali Waelbroeck
Sequences (103-110) and (116-120) of the rat secretin receptor are implicated in secretin and VIP recognition.
Annals of the New York Academy of Sciences 2000;921():362-5.
1999: María G Juarranz; J Van Rampelbergh; P Gourlet; Philippe De Neef; Johnny Cnudde; Patrick Robberecht; Magali Waelbroeck
Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands.
Molecular pharmacology 1999;56(6):1280-7.
1999: A Forgeur; F Willems; J Winand; Patrick Robberecht; Christine Delporte
Natriuretic peptide receptors of type A in human neuroblastomas.
Neuroendocrinology 1999;70(4):288-94.
1999: María G Juarranz; J Van Rampelbergh; P Gourlet; Philippe De Neef; Johnny Cnudde; Patrick Robberecht; Magali Waelbroeck
Vasoactive intestinal polypeptide VPAC1 and VPAC2 receptor chimeras identify domains responsible for the specificity of ligand binding and activation.
European journal of biochemistry / FEBS 1999;265(1):449-56.
1999: María G Juarranz; Philippe De Neef; Patrick Robberecht
Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranes.
The Prostate 1999;41(1):1-6.
1999: Rebeca Busto; María G Juarranz; Salvatore De Maria; Patrick Robberecht; Magali Waelbroeck
Evidence for multiple rat VPAC1 receptor states with different affinities for agonists.
Cellular signalling 1999;11(9):691-6.
1999: E Di Paolo; Philippe De Neef; N Moguilevsky; H Petry; Johnny Cnudde; A Bollen; Magali Waelbroeck; Patrick Robberecht
Properties of a recombinant human secretin receptor: a comparison with the rat and rabbit receptors.
Pancreas 1999;19(1):51-5.
1999: A Forgeur; Michal Svoboda; J Winand; Patrick Robberecht; Christine Delporte
Human A-type ANP receptor upregulation by PACAP and carbachol in neuroblastoma cells.
Molecular and cellular endocrinology 1999;150(1-2):189-93.
1999: V Walraevens; MC Vandermeers-Piret; A Vandermeers; P Gourlet; Patrick Robberecht
Isolation and primary structure of the CCI papain-like cysteine proteinases from the latex of Carica candamarcensis hook.
Biological chemistry 1999;380(4):485-8.
1999: E Di Paolo; J P Vilardaga; H Petry; N Moguilevsky; A Bollen; Patrick Robberecht; Magali Waelbroeck
Role of charged amino acids conserved in the vasoactive intestinal polypeptide/secretin family of receptors on the secretin receptor functionality.
Peptides 1999;20(10):1187-93.
1999: E Di Paolo; H Petry; N Moguilevsky; A Bollen; Philippe De Neef; Magali Waelbroeck; Patrick Robberecht
Mutations of aromatic residues in the first transmembrane helix impair signalling by the secretin receptor.
Receptors & channels 1999;6(4):309-15.
1998: Pascale Vertongen; S N Schiffmann; P Gourlet; Patrick Robberecht
Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain.
Annals of the New York Academy of Sciences 1998;865():412-5.
1998: P Gourlet; A Vandermeers; J Van Rampelbergh; Philippe De Neef; Johnny Cnudde; Magali Waelbroeck; Patrick Robberecht
Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptors.
Annals of the New York Academy of Sciences 1998;865():247-52.
1998: Patrick Robberecht; Magali Waelbroeck
A critical view of the methods for characterization of the VIP/PACAP receptor subclasses.
Annals of the New York Academy of Sciences 1998;865():157-63.
1998: Patrick Robberecht; Philippe De Neef; R A Lefebvre
Influence of selective VIP receptor agonists in the rat gastric fundus.
European journal of pharmacology 1998;359(1):77-80.
1998: P Gourlet; J Rathé; Philippe De Neef; Johnny Cnudde; MC Vandermeers-Piret; Magali Waelbroeck; Patrick Robberecht
Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors.
European journal of pharmacology 1998;354(1):105-11.
1998: P Gourlet; MC Vandermeers-Piret; J Rathé; Philippe De Neef; Johnny Cnudde; Patrick Robberecht; Magali Waelbroeck
Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypes.
European journal of pharmacology 1998;348(1):95-9.
1998: E Di Paolo; Philippe De Neef; N Moguilevsky; H Petry; A Bollen; Magali Waelbroeck; Patrick Robberecht
Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin.
FEBS letters 1998;424(3):207-10.
1998: Michal Svoboda; Michèle Tastenoy; Philippe De Neef; Christine Delporte; Magali Waelbroeck; Patrick Robberecht
Molecular cloning and in vitro properties of the recombinant rabbit secretin receptor.
Peptides 1998;19(6):1055-62.
1998: D Dewit; P Gourlet; Zoulikha Amraoui; Pascale Vertongen; Fabienne Willems; Patrick Robberecht; Michel Goldman
The vasoactive intestinal peptide analogue RO25-1553 inhibits the production of TNF and IL-12 by LPS-activated monocytes.
Immunology letters 1998;60(1):57-60.
1997: Pascale Vertongen; P De Clerck; J C Fournet; H Martelli; P Hélardot; Christine Devalck; Theo L Peeters; Eric Sariban; Patrick Robberecht
Comparison between vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide levels in neuroblastoma tumour tissues.
Neuropeptides 1997;31(5):409-13.
1997: P Gourlet; A Vandermeers; Patrick Robberecht; M Deschodt-Lanckman
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP-27, but not PACAP-38) degradation by the neutral endopeptidase EC 3.4.24.11.
Biochemical pharmacology 1997;54(4):509-15.
1997: J Van Rampelbergh; P Poloczek; I Françoys; Christine Delporte; J Winand; Patrick Robberecht; Magali Waelbroeck
The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins.
Biochimica et biophysica acta 1997;1357(2):249-55.
1997: J P Vilardaga; E Di Paolo; C Bialek; Philippe De Neef; Magali Waelbroeck; A Bollen; Patrick Robberecht
Mutational analysis of extracellular cysteine residues of rat secretin receptor shows that disulfide bridges are essential for receptor function.
European journal of biochemistry / FEBS 1997;246(1):173-80.
1997: P Gourlet; Philippe De Neef; Johnny Cnudde; Magali Waelbroeck; Patrick Robberecht
In vitro properties of a high affinity selective antagonist of the VIP1 receptor.
Peptides 1997;18(10):1555-60.
1997: Pascale Vertongen; S N Schiffmann; P Gourlet; Patrick Robberecht
Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain.
Peptides 1997;18(10):1547-54.
1997: P Gourlet; A Vandermeers; Pascale Vertongen; J Rathe; Philippe De Neef; Johnny Cnudde; Magali Waelbroeck; Patrick Robberecht
Development of high affinity selective VIP1 receptor agonists.
Peptides 1997;18(10):1539-45.
1997: P Gourlet; Pascale Vertongen; A Vandermeers; MC Vandermeers-Piret; J Rathe; Philippe De Neef; Magali Waelbroeck; Patrick Robberecht
The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass.
Peptides 1997;18(3):403-8.
1996: P Gourlet; A Vandermeers; MC Vandermeers-Piret; Philippe De Neef; Magali Waelbroeck; Patrick Robberecht
Effect of introduction of an arginine16 in VIP, PACAP and secretin on ligand affinity for the receptors.
Biochimica et biophysica acta 1996;1314(3):267-73.
1996: J Van Rampelbergh; P Gourlet; Philippe De Neef; Patrick Robberecht; Magali Waelbroeck
Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
Molecular pharmacology 1996;50(6):1596-604.
1996: P Gourlet; J P Vilardaga; Philippe De Neef; A Vandermeers; Magali Waelbroeck; A Bollen; Patrick Robberecht
Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor.
European journal of biochemistry / FEBS 1996;239(2):349-55.
1996: Pascale Vertongen; M Delhase; Fabienne Rajas; Jacqueline Trouillas; Elisabeth L Hooghe-Peters; Michal Svoboda; Patrick Robberecht
Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes are differently expressed in rat transplanted pituitary tumours (SMtTW) and in the normal gland.
Journal of molecular endocrinology 1996;16(3):239-48.
1996: P Gourlet; A Vandermeers; MC Vandermeers-Piret; J Rathé; Philippe De Neef; Patrick Robberecht
C-terminally shortened pituitary adenylate cyclase-activating peptides (PACAP) discriminate PACAP I, PACAP II-VIP1 and PACAP II-VIP2 recombinant receptors.
Regulatory peptides 1996;62(2-3):125-30.
1996: Pascale Vertongen; Christine Devalck; E Sariban; marc-Henri de laet; H Martelli; F Paraf; P Hélardot; Patrick Robberecht
Pituitary adenylate cyclase activating peptide and its receptors are expressed in human neuroblastomas.
Journal of cellular physiology 1996;167(1):36-46.
1996: J P Vilardaga; E Di Paolo; Philippe De Neef; Magali Waelbroeck; A Bollen; Patrick Robberecht
Lysine 173 residue within the first exoloop of rat secretin receptor is involved in carboxylate moiety recognition of Asp 3 in secretin.
Biochemical and biophysical research communications 1996;218(3):842-6.
1996: P Gourlet; J P Vilardaga; Philippe De Neef; Magali Waelbroeck; A Vandermeers; Patrick Robberecht
The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors.
Peptides 1996;17(5):825-9.
1996: Patrick Robberecht; P Gourlet; Pascale Vertongen; Michal Svoboda
Characterization of the VIP receptor from SUP T1 lymphoblasts.
Advances in neuroimmunology 1996;6(1):49-57.
1995: P Gourlet; A Vandermeers; MC Vandermeers-Piret; J Rathé; Philippe De Neef; Patrick Robberecht
Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors.
European journal of pharmacology 1995;287(1):7-11.
1995: J P Vilardaga; Philippe De Neef; E Di Paolo; A Bollen; Magali Waelbroeck; Patrick Robberecht
Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination.
Biochemical and biophysical research communications 1995;211(3):885-91.
1995: E Ciccarelli; M Svoboda; Philippe De Neef; E Di Paolo; A Bollen; C Dubeaux; J P Vilardaga; Magali Waelbroeck; Patrick Robberecht
Pharmacological properties of two recombinant splice variants of the PACAP type I receptor, transfected and stably expressed in CHO cells.
European journal of pharmacology 1995;288(3):259-67.
1995: Christine Delporte; P Poloczek; Philippe De Neef; Pascale Vertongen; E Ciccarelli; Michal Svoboda; A Herchuelz; J Winand; Patrick Robberecht
Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptor.
Molecular and cellular endocrinology 1995;107(1):71-6.
1995: M C Woussen-Colle; P Gourlet; A Vandermeers; MC Vandermeers-Piret; J D'Haens; Brigitte Velkeniers; Patrick Robberecht
Identification of a new chromogranin B fragment (314-365) in endocrine tumors.
Peptides 1995;16(2):231-6.
1995: Pascale Vertongen; J d'Haens; A Michotte; Brigitte Velkeniers; J Van Rampelbergh; Michal Svoboda; Patrick Robberecht
Expression of pituitary adenylate cyclase activating polypeptide and receptors in human brain tumors.
Peptides 1995;16(4):713-9.
1994: Michal Svoboda; Michèle Tastenoy; J Van Rampelbergh; J F Goossens; Philippe De Neef; Magali Waelbroeck; Patrick Robberecht
Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts.
Biochemical and biophysical research communications 1994;205(3):1617-24.
1994: E Ciccarelli; J P Vilardaga; Philippe De Neef; E Di Paolo; Magali Waelbroeck; A Bollen; Patrick Robberecht
Properties of the VIP-PACAP type II receptor stably expressed in CHO cells.
Regulatory peptides 1994;54(2-3):397-407.
1994: Michal Svoboda; Michèle Tastenoy; Pascale Vertongen; Patrick Robberecht
Relative quantitative analysis of glucagon receptor mRNA in rat tissues.
Molecular and cellular endocrinology 1994;105(2):131-7.
1994: Pascale Vertongen; E Ciccarelli; M C Woussen-Colle; Philippe De Neef; Patrick Robberecht; A Cauvin
Pituitary adenylate cyclase-activating polypeptide receptors of types I and II and glucagon-like peptide-I receptors are expressed in the rat medullary carcinoma of the thyroid cell line 6/23.
Endocrinology 1994;135(4):1537-42.
1994: X Hou; A Vandermeers; P Gourlet; MC Vandermeers-Piret; Patrick Robberecht
Structural requirements for the occupancy of rat brain PACAP receptors and adenylate cyclase activation.
Neuropharmacology 1994;33(10):1189-95.
1994: Patrick Robberecht; Philippe De Neef; M C Woussen-Colle; Pascale Vertongen; O De Witte; J Brotchi
Presence of calcitonin gene-related peptide receptors coupled to adenylate cyclase in human gliomas.
Regulatory peptides 1994;52(1):53-60.
1994: J P Vilardaga; E Ciccarelli; C Dubeaux; Philippe De Neef; A Bollen; Patrick Robberecht
Properties and regulation of the coupling to adenylate cyclase of secretin receptors stably transfected in Chinese hamster ovary cells.
Molecular pharmacology 1994;45(5):1022-8.
1994: S F Nilsson; Philippe De Neef; Patrick Robberecht; J Christophe
Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase.
Experimental eye research 1994;58(4):459-67.
1994: M C Woussen-Colle; P Lingier; Pascale Vertongen; MC Vandermeers-Piret; A Vandermeers; Patrick Robberecht
Chromogranin A(210-301) is the major form of pancreastatin-like material in human gut extracts and endocrine tumors.
Peptides 1994;15(5):869-74.
1994: Patrick Robberecht; M C Woussen-Colle; Pascale Vertongen; Philippe De Neef; X Hou; I Salmon; J Brotchi
Expression of pituitary adenylate cyclase activating polypeptide (PACAP) receptors in human glial cell tumors.
Peptides 1994;15(4):661-5.
1993: Michal Svoboda; E Ciccarelli; Michèle Tastenoy; Patrick Robberecht; J Christophe
A cDNA construct allowing the expression of rat hepatic glucagon receptors.
Biochemical and biophysical research communications 1993;192(1):135-42.
1992: A Vandermeers; S Vandenborre; X Hou; Philippe De Neef; Patrick Robberecht; MC Vandermeers-Piret; J Christophe
Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes.
European journal of biochemistry / FEBS 1992;208(3):815-9.
1992: Louis Buscail; C Cambillau; Catherine Seva; J L Scemama; Philippe De Neef; Patrick Robberecht; J Christophe; Christiane Susini; Nicole Vaysse
Stimulation of rat pancreatic tumoral AR4-2J cell proliferation by pituitary adenylate cyclase-activating peptide.
Gastroenterology 1992;103(3):1002-8.
1992: Patrick Robberecht; P Gourlet; Philippe De Neef; M C Woussen-Colle; MC Vandermeers-Piret; A Vandermeers; J Christophe
Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
Molecular pharmacology 1992;42(2):347-55.
1992: Patrick Robberecht; P Gourlet; Philippe De Neef; M C Woussen-Colle; MC Vandermeers-Piret; A Vandermeers; J Christophe
Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist.
European journal of biochemistry / FEBS 1992;207(1):239-46.
1991: A Cauvin; Patrick Robberecht; Philippe De Neef; P Gourlet; A Vandermeers; MC Vandermeers-Piret; J Christophe
Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord.
Regulatory peptides 1991;35(2):161-73.
1991: Patrick Robberecht; M C Woussen-Colle; Philippe De Neef; P Gourlet; L Buscail; A Vandermeers; MC Vandermeers-Piret; J Christophe
The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP (1-27) and PACAP (1-38)) interact with distinct receptors on rat pancreatic AR 4-2J cell membranes.
FEBS letters 1991;286(1-2):133-6.
1991: P Gourlet; Philippe De Neef; M C Woussen-Colle; A Vandermeers; MC Vandermeers-Piret; Patrick Robberecht; J Christophe
The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes.
Biochimica et biophysica acta 1991;1066(2):245-51.
1991: Y Bounjoua; A Vandermeers; Patrick Robberecht; MC Vandermeers-Piret; J Christophe
Purification and amino acid sequence of vasoactive intestinal peptide, peptide histidine isoleucinamide and secretin from the ovine small intestine.
Regulatory peptides 1991;32(2):169-79.
1991: A Cauvin; Philippe De Neef; E Bastianelli; Patrick Robberecht; J Christophe
Variable distribution, in four rat brain areas, of the three natural forms of peptide histidine isoleucinamide: PHI(1-27)NH2, PHI-Gly, and PHV (1-42).
Neuroendocrinology 1991;53(2):190-3.
1991: P Gourlet; M C Woussen-Colle; Patrick Robberecht; Philippe De Neef; A Cauvin; MC Vandermeers-Piret; A Vandermeers; J Christophe
Structural requirements for the binding of the pituitary adenylate-cyclase-activating peptide to receptors and adenylate-cyclase activation in pancreatic and neuronal membranes.
European journal of biochemistry / FEBS 1991;195(2):535-41.
1991: A Cauvin; L Buscail; P Gourlet; Philippe De Neef; Patrick Robberecht; N Yanaihara; J Christophe
Comparative in vitro effects of guinea pig VIP and common VIP on liver and lung membranes from guinea pig and rat and on human lymphoblastic SUP-T1 membranes.
Peptides 1991;12(1):139-43.
1991: Patrick Robberecht; P Gourlet; A Cauvin; L Buscail; Philippe De Neef; A Arimura; J Christophe
PACAP and VIP receptors in rat liver membranes.
The American journal of physiology 1991;260(1 Pt 1):G97-102.
1991: Patrick Robberecht
New perspectives in cardiac receptors.
Acta cardiologica 1991;46(3):291-7.
1991: P Gourlet; Patrick Robberecht; J Christophe
Molecular characterization of helodermin-preferring VIP receptors in SUP T1 lymphoma cells: evidence for receptor glycosylation.
Journal of receptor research 1991;11(5):831-48.
1990: D Gossen; Michèle Tastenoy; Patrick Robberecht; J Christophe
Secretin receptors in the neuroglioma hybrid cell line NG108-15. Characterization and regulation of their expression.
European journal of biochemistry / FEBS 1990;193(1):149-54.
1990: A Cauvin; MC Vandermeers-Piret; A Vandermeers; E Coussaert; Philippe De Neef; Patrick Robberecht; J Christophe
Rat PHI, PHI-GLY and PHV (1-42) stimulate adenylate cyclase in six rat tissue and cell membranes.
Peptides 1990;11(5):1009-14.
1990: L Buscail; Patrick Robberecht; P DeNeef; D N Bui; R Hooghe; J Christophe
Divergent regulation of beta 2-adrenoceptors and adenylate cyclase in the Cyc- mouse T lymphoma cell line TL2-9.
Immunobiology 1990;181(1):51-63.
1990: A Cauvin; L Buscail; P Gourlet; Philippe De Neef; D Gossen; A Arimura; A Miyata; D H Coy; Patrick Robberecht; J Christophe
The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK.
Peptides 1990;11(4):773-7.
1990: L Buscail; A Cauvin; P Gourlet; D Gossen; Philippe De Neef; J Rathé; Patrick Robberecht; MC Vandermeers-Piret; A Vandermeers; J Christophe
Purification and amino acid sequence of vasoactive intestinal peptide, peptide histidine isoleucinamide (1-27) and secretin from the small intestine of guinea pig.
Biochimica et biophysica acta 1990;1038(3):355-9.
1990: L Buscail; P Gourlet; A Cauvin; Philippe De Neef; D Gossen; A Arimura; A Miyata; D H Coy; Patrick Robberecht; J Christophe
Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J.
FEBS letters 1990;262(1):77-81.
1990: D Gossen; L Buscail; A Cauvin; P Gourlet; Philippe De Neef; J Rathe; Patrick Robberecht; MC Vandermeers-Piret; A Vandermeers; J Christophe
Amino acid sequence of VIP, PHI and secretin from the rabbit small intestine.
Peptides 1990;11(1):123-8.
1990: Patrick Robberecht; A Cauvin; P Gourlet; J Christophe
Heterogeneity of VIP receptors.
Archives internationales de pharmacodynamie et de thérapie 1990;303():51-66.
1990: J Christophe; A Cauvin; E Vervisch; L Buscail; C Damien; J Abello; P Gourlet; Patrick Robberecht
VIP receptors in human SUP-T1 lymphoblasts.
Digestion 1990;46 Suppl 2():148-55.
1989: A Cauvin; A Vandermeers; MC Vandermeers-Piret; Patrick Robberecht; J Christophe
Variable distribution of three molecular forms of peptide histidine isoleucinamide in rat tissues: identification of the large molecular form as peptide histidine valine-(1-42).
Endocrinology 1989;125(5):2645-55.
1989: Patrick Robberecht; J Abello; C Damien; Philippe De Neef; E Vervisch; R Hooghe; J Christophe
Variable stimulation of adenylate cyclase activity by vasoactive intestinal-like peptides and beta-adrenergic agonists in murine T cell lymphomas of immature, helper, and cytotoxic types.
Immunobiology 1989;179(4-5):422-31.
1989: A Cauvin; A Vandermeers; MC Vandermeers-Piret; J Rathe; Patrick Robberecht; J Christophe
Peptide histidine isoleucinamide (PHI)-(1-27)-Gly as a new major form of PHI in the rat small intestine.
Endocrinology 1989;125(3):1296-302.
1989: C Damien; Patrick Robberecht; R Hooghe; Philippe De Neef; J Christophe
Decreased adenylate cyclase activation by helodermin and PGE1 in the lectin-resistant variant Wa4 of the mouse melanoma cell line B16.
Peptides 1989;10(5):1075-9.
1989: Patrick Robberecht; Philippe De Neef; J Abello; C Damien; E Coussaert; J Christophe
Recovery of VIP/helodermin- and prostaglandin E1-stimulated adenylate cyclase activities in desensitized SUP-T1 human lymphoblasts.
Peptides 1989;10(5):1027-31.
1989: Patrick Robberecht; Philippe De Neef; P Gourlet; A Cauvin; D H Coy; J Christophe
Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes.
Regulatory peptides 1989;26(2):117-26.
1989: Patrick Robberecht; Philippe De Neef; L Buscail; J Christophe
The phorbol ester TPA stimulates the expression of functional beta-adrenoceptors in human T lymphoblasts Molt 3.
The Biochemical journal 1989;261(3):959-63.
1989: J Abello; C Damien; Patrick Robberecht; R Hooghe; A Vandermeers; MC Vandermeers-Piret; J Christophe
Homologous and heterologous regulation of the helodermin/vasoactive-intestinal-peptide response in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
European journal of biochemistry / FEBS 1989;183(2):269-74.
1989: J Abello; C Damien; Philippe De Neef; Michèle Tastenoy; R Hooghe; Patrick Robberecht; J Christophe
Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
European journal of biochemistry / FEBS 1989;183(2):263-7.
1989: D Gossen; A Vandermeers; MC Vandermeers-Piret; J Rathé; A Cauvin; Patrick Robberecht; J Christophe
Isolation and primary structure of rat secretin.
Biochemical and biophysical research communications 1989;160(2):862-7.
1989: Patrick Robberecht; Philippe De Neef; Magali Waelbroeck; Michèle Tastenoy; J Christophe
VIP and related peptides induce rapid homologous desensitization in the human lymphoma SUP T1 cell line.
Peptides 1989;10(2):441-6.
1989: J Abello; Patrick Robberecht; C Damien; J Christophe
Desensitization and recovery of prostaglandin-stimulated adenylate cyclase activity in a murine virus-induced T lymphoma cell line BL/VL3.
Journal of receptor research 1989;9(6):451-63.
1989: C Damien; Patrick Robberecht; J Abello; R Hooghe; J Christophe
VIP-helodermin receptors in the murine virus-induced T lymphoma cell line BL/VL3 recover less rapidly than beta-adrenoceptors after down regulation.
Journal of receptor research 1989;9(6):441-9.
1988: J L Scemama; Patrick Robberecht; Magali Waelbroeck; Philippe De Neef; Lucien Pradayrol; Nicole Vaysse; J Christophe
CCK and gastrin inhibit adenylate cyclase activity through a pertussis toxin-sensitive mechanism in the tumoral rat pancreatic acinar cell line AR 4-2J.
FEBS letters 1988;242(1):61-4.
1988: Michal Svoboda; P Poloczek; J Winand; Patrick Robberecht; J Christophe
Species differences in the molecular characteristics of vasoactive-intestinal-peptide receptors in the pancreas from rat and guinea-pig.
European journal of biochemistry / FEBS 1988;174(1):59-66.
1988: Patrick Robberecht; Magali Waelbroeck; Philippe De Neef; J C Camus; D H Coy; J Christophe
Pharmacological characterization of VIP receptors in human lung membranes.
Peptides 1988;9(2):339-45.
1988: Patrick Robberecht; Magali Waelbroeck; Philippe De Neef; Michèle Tastenoy; P Gourlet; J Cogniaux; J Christophe
A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts.
FEBS letters 1988;228(2):351-5.
1988: Patrick Robberecht; A Vandermeers; MC Vandermeers-Piret; P Gourlet; A Cauvin; Philippe De Neef; J Christophe
Helodermin-like peptides.
Annals of the New York Academy of Sciences 1988;527():186-203.
1988: Magali Waelbroeck; J Camus; Michèle Tastenoy; Philippe De Neef; J L Scemama; Daniel Fourmy; Nicole Vaysse; Lucien Pradayrol; Patrick Robberecht; J Christophe
Characterization of muscarinic receptors in human pancreatic membranes.
Pancreas 1988;3(6):627-30.
1988: Magali Waelbroeck; Patrick Robberecht; Philippe De Neef; J Christophe
Effects of d-tubocurarine on rat cardiac muscarinic receptors: a comparison with gallamine.
Journal of receptor research 1988;8(6):787-808.
1988: Patrick Robberecht; Philippe De Neef; Magali Waelbroeck; J C Camus; J L Scemama; Daniel Fourmy; Lucien Pradayrol; Nicole Vaysse; J Christophe
Secretin receptors in human pancreatic membranes.
Pancreas 1988;3(5):529-35.
1988: J Christophe; Michal Svoboda; Magali Waelbroeck; J Winand; Patrick Robberecht
Vasoactive intestinal peptide receptors in pancreas and liver. Structure-function relationship.
Annals of the New York Academy of Sciences 1988;527():238-56.
1988: Patrick Robberecht; Magali Waelbroeck; Philippe De Neef; J C Camus; P Gourlet; J Christophe
Effect of freezing on the coupling of VIP receptors to adenylate cyclase in rat liver membranes.
Life sciences 1988;42(5):505-10.
1987: A Vandermeers; P Gourlet; MC Vandermeers-Piret; A Cauvin; Philippe De Neef; J Rathe; Michal Svoboda; Patrick Robberecht; J Christophe
Chemical, immunological and biological properties of peptides like vasoactive-intestinal-peptide and peptide-histidine-isoleucinamide extracted from the venom of two lizards (Heloderma horridum and Heloderma suspectum).
European journal of biochemistry / FEBS 1987;164(2):321-7.
1986: J P Dehaye; J Winand; C Damien; F Gomez; P Poloczek; Patrick Robberecht; A Vandermeers; MC Vandermeers-Piret; M Stiévenart; J Christophe
Receptors involved in helodermin action on rat pancreatic acini.
The American journal of physiology 1986;251(5 Pt 1):G602-10.